
Docs Who Lift
Drs. Spencer and Karl Nadolsky talk about nutrition, medicine, and fitness through the lens of two physicians who lift weights. Both doctors are former NCAA division 1 wrestlers who have gone into medicine. Dr. Spencer Nadolsky is a board certified family physician specialized in obesity medicine and lipidology. Dr. Karl Nadolsky is a board certified endocrinologist also specialized in obesity medicine.
Latest episodes

May 29, 2025 • 56min
Current State of Nutrition Research and MAHA
Kevin Klatt, a nutrition PhD and insightful commentator on dietary guidelines, discusses the pressing issues of nutrition research. He criticizes the MAHA report for lacking actionable policies despite addressing public health concerns. Klatt emphasizes the historical context of nutrition guidelines and the inadequacy of current funding for research. He argues that misinformation and political agendas undermine public trust, calling for more rigorous science to inform policy. Ultimately, he advocates for a shift towards policies prioritizing genuine health outcomes over superficial changes.

May 13, 2025 • 47min
Joy Prescriptions
Tiffany Moon is an anesthesiologist, associate professor, and former star of The Real Housewives of Dallas, who brings her unique perspective on finding joy and purpose in life. She discusses her journey from reality TV to embracing a life centered around genuine connections. Tiffany emphasizes the importance of work-life integration and how to break free from perfectionism. She also shares insights from the Lead Her Summit, aimed at empowering women, and highlights the significance of gratitude in sustaining happiness and fulfillment.

18 snips
May 12, 2025 • 21min
Zepbound versus Wegovy
Discover the battle of weight loss medications with tirzepatide showing superior effectiveness over semaglutide. Unpack the complexities of drug pricing and the critical need for affordable access to treatments for severe obesity. Gender influences on weight loss outcomes are explored, alongside the safety and tolerability of these medications. Long-term studies reveal promising benefits beyond weight loss, including improvements in metabolic health. Get the scoop on future research directions, particularly regarding cardiovascular impacts.

May 2, 2025 • 22min
Semaglutide for metabolic dysfunction associated steatotic liver disease (MASH).
TakeawaysMASH is a significant obesity-related complication.Semaglutide shows promise in treating MASH.Weight loss is crucial for improving liver health.Bariatric surgery remains the most effective treatment.The Essence trial indicates a 63% resolution of NASH.New medications are being developed for obesity treatment.Early intervention is key to preventing severe liver damage.Accessibility of medications is a major concern.Comparative studies are essential for evaluating new treatments.Future treatments may include innovative delivery methods.Chapters00:00 Introduction to MASH and Semaglutide Study04:29 Understanding Metabolic Dysfunction and Its Implications08:02 Essence Trial: Semaglutide's Impact on MASH12:58 Comparative Analysis of New Treatments for MASH17:30 The Future of Obesity Treatment and Drug AccessibilityJoin Vineyard - Dr. Spencer's online clinicSee the study

Apr 25, 2025 • 37min
Top 5 Women's Fitness Myths
Drs. Karl and Spencer chat with return guest Dr. Lauren Semple about creatine, protein, cortisol, fasting exercise, and training in women.Follow Dr. Lauren's instagramJoin Dr. Spencer's online clinic

9 snips
Apr 11, 2025 • 25min
GLP-1 and metabolism and depression
Explore the fascinating effects of tirzepatide on metabolic rates and its surprising links to depression. Discover the real-life implications and psychological risks of GLP-1 medications like semaglutide. Delve into personal stories of overcoming weight loss plateaus through the interplay of mental and physical health. Learn about the costs and accessibility challenges of obesity treatments, and how these affect patients' ability to maintain their health. Join the conversation on modern solutions and the future of diabetes management!

Mar 19, 2025 • 26min
Do GLP-1 meds cause more fat cells?
Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells.Learn about if and how GLP-1 meds increase fat cells and what that means along with other claims about these medicine.Join Dr. Spencer's online clinic that specializes in GLP-1 medicines

Mar 11, 2025 • 23min
Future of medicine - Direct Care
Drs. Karl and Spencer talk to Dr. Kenneth Qiu all about direct medical care - the future of medicine.Learn about how bypassing insurance and creating a relationship directly with a doctor can improve your health and save money in the long run.Follow Dr. Qiu on Linked inSee Dr. Spencer's direct care model with Vineyard

16 snips
Feb 28, 2025 • 28min
Tirzepatide and Muscle Loss with Dr. Grant Tinsley
In this engaging conversation, Dr. Grant Tinsley, an Associate Professor at Texas Tech University and a body composition expert, discusses the impact of tirzepatide, a leading weight loss medication, on muscle loss. He clarifies the differences between fat-free mass, lean mass, and muscle, emphasizing the importance of precise language in the field. Tinsley also examines how DEXA scans can motivate weight training, strategies to preserve muscle while using tirzepatide, and the need for a holistic approach to muscle growth through nutrition and exercise.

Feb 17, 2025 • 25min
The Super Bowl Hims and Hers Ad
Drs. Karl and Spencer discuss how bad the Hims and Hers ad was.From an outside perspective, the ad may have seemed good.But when you dig deeper, it was actually really bad.Listen to learn.Join Dr. Spencer's new online clinic - Vineyard.